Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity

Alan S Premasiri1, Anna L Gill1, Fernando G Vieira1

  • 1ALS Therapy Development Institute, Cambridge, MA, United States.

Insights

Small molecules targeting protein arginine methyltransferases (PRMTs) reduce toxicity from C9ORF72 repeat expansions, a key cause of ALS and FTD. This suggests PRMT inhibition is a potential therapeutic strategy for these neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • C9ORF72 repeat expansions are the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
  • These expansions produce toxic dipeptide repeat proteins (DRPs), with arginine-containing polyGR and polyPR being particularly harmful.

Purpose of the Study:

  • To investigate the role of protein arginine methyltransferases (PRMTs) in the toxicity of polyGR and polyPR.
  • To evaluate the therapeutic potential of inhibiting Type I PRMTs against C9ORF72-associated neurotoxicity.

Main Methods:

  • Utilized cell models expressing polyGR and polyPR to assess toxicity.
  • Administered small molecule inhibitors targeting Type I PRMTs.
  • Analyzed the impact of PRMT inhibition on DRP cytotoxicity and methylation status.

Main Results:

  • Small molecule inhibition of Type I PRMTs significantly protected against polyGR and polyPR toxicity.
  • Evidence suggests that asymmetric dimethylation of polyGR and polyPR by Type I PRMTs is crucial for their cytotoxic effects.

Conclusions:

  • Type I PRMTs and their methylation activity are key contributors to the toxicity of C9ORF72-associated DRPs.
  • Inhibiting Type I PRMTs represents a promising therapeutic avenue for treating ALS and FTD caused by C9ORF72 repeat expansions.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
10.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.4K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.0K